BRIEF published on 02/03/2026 at 12:17, 1 month 22 days ago GeNeuro SA bankrupt after the end of the composition moratorium Biopharmaceutical Bankruptcy GeNeuro Geneva Court Concordat Moratorium
BRIEF published on 02/03/2026 at 12:14, 1 month 22 days ago GeNeuro SA Declares Bankruptcy Following Debt Moratorium Biopharmaceutical Bankruptcy Court Ruling GeNeuro SA Debt Moratorium
PRESS RELEASE published on 02/03/2026 at 12:09, 1 month 22 days ago INSIDE INFORMATION / OTHER NEWS RELEASES GeNeuro SA announces the end of debt moratorium and commencement of bankruptcy proceedings after Geneva Court ruling. Further details in official publications Biopharmaceutical Company GeNeuro SA Bankruptcy Proceedings Debt Moratorium Geneva Court Ruling
BRIEF published on 01/23/2026 at 11:05, 2 months 2 days ago GeNeuro SA Suspends Trading Ahead of Court Ruling Euronext Paris Trading Suspension GeNeuro Debt Moratorium Geneva Court
BRIEF published on 01/23/2026 at 11:05, 2 months 2 days ago Temporary suspension of trading of GeNeuro SA shares on Euronext Paris Restructuring GeNeuro SA Geneva Court Trading Suspended Concordat Moratorium
PRESS RELEASE published on 01/23/2026 at 11:00, 2 months 2 days ago Inside Information / Other news releases GeNeuro SA requests temporary suspension of trading on Euronext Paris pending Geneva Court judgment on debt moratorium. Details on debt restructuring and impact on operations Euronext Paris GeNeuro SA Swiss Law Temporary Suspension Debt Moratorium
BRIEF published on 10/15/2025 at 20:30, 5 months 10 days ago GeNeuro Delays Half-Year Financial Report Release Financial Report Restructuring Biopharmaceutical GeNeuro Debt Moratorium
PRESS RELEASE published on 10/15/2025 at 20:25, 5 months 10 days ago Inside Information / Other news releases GeNeuro SA postpones the publication of June 30, 2025 half-yearly financial report to assess financial impacts of debt-restructuring moratorium extension. New date to be announced Financial Report Postponement Neurological Disorders GeNeuro SA Debt-restructuring Moratorium
BRIEF published on 09/26/2025 at 18:41, 5 months 29 days ago GeNeuro SA: Extension of the debt restructuring stay until 2026 Restructuring GeNeuro Neurological Diseases Composition Stay Geneva Court
PRESS RELEASE published on 09/26/2025 at 18:36, 5 months 29 days ago Inside Information / Other news releases GeNeuro SA extends its definitive debt-restructuring moratorium until January 27, 2026, to explore strategic options and continue developing treatments for neurodegenerative and autoimmune diseases Autoimmune Diseases GeNeuro SA Neurodegenerative Diseases Debt-restructuring Moratorium
Published on 03/26/2026 at 04:55, 1 hour 33 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 5 hours 48 minutes ago Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 5 hours 58 minutes ago Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 11 hours 13 minutes ago Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/25/2026 at 13:30, 16 hours 58 minutes ago Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
Published on 03/26/2026 at 06:06, 22 minutes ago Bajaj Mobility AG Annual Financial Report 2025: Successful Turnaround Following an Intensive Year of Restructuring – Operational Stabilization and Record Motorsport Season
Published on 03/26/2026 at 06:00, 27 minutes ago Bajaj Mobility AG confirms revenue and earnings for 2025 and publishes the annual report 2025
Published on 03/26/2026 at 04:45, 1 hour 43 minutes ago Powering global maritime decarbonization, Shanghai Electric delivers first large-scale biomethanol bunkering for international shipping
Published on 03/26/2026 at 01:05, 5 hours 23 minutes ago Blokees Announces Upgrade Brand Mission at 2026 Global Partner Conference
Published on 03/25/2026 at 20:00, 10 hours 28 minutes ago Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
Published on 03/25/2026 at 18:31, 11 hours 57 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 12 hours 43 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
